During hepatitis C virus (HCV) chronic infection, extrahepatic manifestations are frequent
and polymorphous. This article reports on a large cohort of patients with HCV-related …

Answer questions and earn CME/CNE Extranodal marginal zone lymphoma of the mucosa‐
associated lymphoid tissue (MALT lymphoma) accounts for 7% to 8% of newly diagnosed …

In the last update of the World Health Organization (WHO) classification, the marginal zone
B-cell lymphomas (MZLs) comprise extranodal MZL (EMZL) of mucosa-associated lymphoid …

Hepatitis C virus (HCV) infected patients are known to be at risk of develo** liver
complications ie cirrhosis and liver cancer. However, the risks of morbidity and mortality are …

Hepatitis C virus (HCV)‐associated mixed cryoglobulinemia (MC) vasculitis commonly
regresses upon virus eradication, but conventional therapy with pegylated interferon and …

Regression of hepatitis C virus (HCV)–associated lymphoma with interferon (IFN)-based
antiviral treatment supports an etiological link between lymphoma and HCV infection. In …

Splenic marginal zone lymphoma (SMZL) is a rare B-cell malignancy involving the spleen,
bone marrow, and frequently the blood. SMZL lymphomagenesis involves antigen and/or …

The clinical course of chronic hepatitis C virus (HCV) infection is characterized by possible
development of both liver and extrahepatic disorders. The tropism of HCV for the lymphoid …

Background and aim Chronic HCV infection is associated with several extrahepatic
manifestations (EHMs). Data on the effect of sustained virological response (SVR) on the …

Hepatitis C virus (HCV) replication requires annealing of a liver specific microRNA, miR-122
to 2 sites on 5′ untranslated region (UTR). While, microRNAs downregulate gene …